The Indian Journal of Pediatrics

, Volume 86, Issue 2, pp 116–117 | Cite as

West Syndrome: Questions Aplenty- Few Answers

  • Shivan Kesavan
  • Naveen SankhyanEmail author
Editorial Commentary

West syndrome is an infantile-onset epileptic encephalopathy, characterized by epileptic spasms, developmental delay or regression, and hypsarrythmia on the EEG [1]. Though it can result from genetic or metabolic causes, a structural etiology is most commonly identified in Indian children [2]. In addition to the epileptic spasms, affected children are at high risk for developmental disabilities, intellectual and behavioral abnormalities, and long-term epilepsy. Epileptic spasms are unique in that they are resistant to most conventional antiepileptic drugs and hormonal therapy with corticosteroids has proven to be the most effective treatment. The mechanism of action of corticosteroids on epileptic spasms is still unclear, but it is believed that it is due to inhibition of Corticotropin-releasing hormone (CRH) overexpression in these children. Though high-dose Adrenocorticotropic hormone (ACTH) had been the standard of treatment, based on limited evidence, international guidelines...


Compliance with Ethical Standards

Conflict of Interest


Source of Funding



  1. 1.
    Lux AL, Osborne JP. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group. Epilepsia. 2004;45:1416–28.CrossRefGoogle Scholar
  2. 2.
    Kaushik JS, Patra B, Sharma S, Yadav D, Aneja S. Clinical spectrum and treatment outcome of West syndrome in children from Northern India. Seizure. 2013;22:617–21.CrossRefGoogle Scholar
  3. 3.
    Go CY, Mackay MT, Weiss SK, et al. Evidence-based guideline update: medical treatment of infantile spasms. Report of the guideline development Subcommittee of the American Academy of neurology and the practice Committee of the Child Neurology Society. Neurology. 2012;78:1974–80.CrossRefGoogle Scholar
  4. 4.
    Nelson GR. Management of infantile spasms. Transl Pediatr. 2015;4:260–70.Google Scholar
  5. 5.
    Sahu JK. Infantile spasms--evidence based medical management. Indian J Pediatr. 2014;81:1052–5.CrossRefGoogle Scholar
  6. 6.
    Sharma S, Sankhyan N, Gulati S, Agarwala A. Use of the modified Atkins diet in infantile spasms refractory to first-line treatment. Seizure. 2012;21:45–8.CrossRefGoogle Scholar
  7. 7.
    Gowda VK, Narayanaswamy V, Shivappa SK, Benakappa N, Benakappa A. Corticotrophin-ACTH in comparison to prednisolone in West syndrome - a randomized study. Indian J Pediatr. 2018.
  8. 8.
    Demarest ST, Shellhaas RA, Gaillard WD, et al. The impact of hypsarrhythmia on infantile spasms treatment response: observational cohort study from the National Infantile Spasms Consortium. Epilepsia. 2017;58:2098–103.CrossRefGoogle Scholar
  9. 9.
    Baram TZ, Mitchell WG, Tournay A, Snead OC, Hanson RA, Horton EJ. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics. 1996;97:375–9.Google Scholar
  10. 10.
    Kondo Y, Okumura A, Watanabe K, et al. Comparison of two low dose ACTH therapies for west syndrome: their efficacy and side effect. Brain Dev. 2005;27:326–30.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2019

Authors and Affiliations

  1. 1.Pediatric Neurology Unit, Department of Pediatrics, Advanced Pediatric CentrePost Graduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations